ince the first description of the Brugada syndrome (BS) by Brugada and Brugada, 1 there have been many studies from Japan characterizing the syndrome, partly because of the high prevalence of BS in Asian countries. In the review by Alings and Wilde in 1999 58% of 163 patients who met the criteria for BS were of Asian origin. 2 Another reason for BS to attract so much clinical and research interest is the fact that apparently healthy individuals are victims of sudden cardiac death (SCD). Furthermore, one of the most important diagnostic parameters of BS is easily detected by routine ECG examination, so that not only cardiologists but also other physicians can recognize suspected individuals. Among the various reports dealing with BS and related conditions, the disease characteristics share a certain similarity and dissimilarity among Japanese patients and those from elswhere. This review will focus on the significant contribution of studies done in Japan to our understanding of the clinical and mechanistic features of BS by the year of 2006.
Incidence and Prevalence of BS
The actual incidence of BS in the general population is difficult to estimate because the typical ECG signs (ST-segment elevation in V1-3) are prone to fluctuate in appearance with time, and there are significant numbers of individuals demonstrating unequivocal ECG changes without clinical symptoms of syncope and/or aborted SCD, or a family history of SCD. 9, 10 According to previous studies, the incidence of BS in the general population of Japan ranges from 0.04% to 1.22%. [11] [12] [13] [14] [15] [16] Miyasaka et al 11 examined the incidence of ECG signs of the BS-type in a community-based general population (Moriguchi, Osaka) and found that the incidence of subjects showing RBBB with ST elevation ≥0.1 mV was 0.70% of the total adult population and 2.14% among men. A typical BS-type ECG (coved-type ST elevation) accounted for 0.12% of 13,929 subjects, with apparent male predominance. Matsuo et al 12 studied the ECG records from biennial health examinations conducted between 1958 and 1999 as follow-up studies of atomic bomb victims in Nagasaki and Hiroshima cities. Among 4,788 subjects, there were 0.15% of cases showing ST elevation ≥0.1 mV of either the coved-or saddleback-type. Of a total of 32 BS-type ECG cases, the prevalence was 146.2 in 100,000 persons and the incidence was 14.2 persons/100,000 person-year. The incidence was 9-fold higher in men than in women. Sakabe et al 13 followed up the ECGs of 3,339 healthy subjects who underwent periodic medical examinations from 1992 to 2002. None of the subjects had a family history of SCD. Their results gave the annual mean proportion of 1.22% for ST elevation (J-point elevation) ≥0.2 mV, including the coved-and saddlebacktype. The majority of them (97%) were men and the male incidence of coved-type ST elevation was 0.28%. Other studies of annual health check-ups in working populations gave a similar incidence of the coved-type (Type 1) ST elevation. [14] [15] [16] Most of those reports dealt with adult populations and disclosed that the incidence of a typical BS-type ECG (coved-type ST-segment elevation) was in a range of 0.12-0.28% of subjects. The incidence of BS-type ECGs in the Japanese adult population appears to be generally higher than in Europe and the USA. 2, 6, [17] [18] [19] In school-aged children, the incidence of BS is very low, compared with adults. Yamakawa et al 20 studied the incidence of children with RBBB and ST-segment elevation ≥0.1 mV (coved-and saddleback-type). Of the children aged between 6 and 15 years old 0.054% had these ECG signs and 91% were boys. Coved-type ST elevation in these children was 0.005%. The researchers also noticed the incidence of positive ECG signs increased with age.
As to prognosis, Miyasaka et al did not notice any increase in risk of SCD in the subjects with BS-type ECG signs, 11 although Matsuo et al, in contrast, claimed there was an increased risk of unexpected death among individuals with BS-type ECG signs, compared witho those without the signs. 12 Their different results might relate to the longer follow-up period in the latter study. These and other studies dealing with general populations seem to represent asymptomatic BS and the overall rate of SCD or arrhythmic events was approximately 0.5%. [13] [14] [15] [16] 
Pathophysiological Mechanism of BS
The mechanism of ST-segment elevation in V1-3 is explained by the voltage difference between the epicardial and endocardial cells of the right ventricular outflow tract (RVOT) region, where the former has a well developed transient outward current (Ito) and the latter has the least development of Ito. With a decrease in the inward currents, especially the fast Na + current (INa), the transmural voltage difference during the early repolarization at the RVOT is accentuated and causes a prominent J wave and ST-segment elevation in V1-3. Increased heterogeneity of repolarization between the epicardium and endocardium, or even among contagious epicardial cells, would cause "phase 2 reentry", leading to polymorphic ventricular tachycardia (VT) and VF. 6, 21 The involvement of the INa in the genesis of ST-segment elevation was first suggested in an early report by Miyazaki et al, who demonstrated that class Ia drugs, but not class Ib, increased ST-segment elevation in patients with BS. 22 An accidental finding of ST elevation induced by flecainide treatment for paroxysmal atrial fibrillation (AF) was first noted by Nakazato et al in 1977. 23 Accordingly, strong evidence for sodium-channel blockers causin BS-type ECG changes was presented by Krishnan and Josephson in 1998 24 and by Fujiki et al in 1999. 25 Those 2 studies indicated that class Ic agents were prone to producing or aggravating ST-segment elevation in BS patients, supporting the notion of decreased INa as the possible underlying electrophysiological mechanism for the ECG changes. Shimizu et al 26 examined the efficacy of different sodium-channel blockers on the induction or unmasking of ST-segment elevation. Among these drugs, class Ic agents could most effectively amplify or unmask ST-segment elevation because of their strong INa blocking action, whereas class Ia and Ib agents had moderate or minimal effects on ST-segment elevation, respectively, because of their relatively weak INa blocking action. These provocation effects of sodium-channel blockers were then applied in their use as a diagnostic tool or a marker for risk stratification. 10, 27, 28 Another mechanistic explanation of the ECG changes in BS is a repolarization abnormality in the epicardium of the RVOT region. Kurita et al 29 studied the monophasic action potential (MAP) recordings from the epicardium and endocardium of a patient with BS during ICD implantation. The MAP from the epicardium showed a deep notch during the early plateau, whereas the MAP from the endocardium had a minimal notch, indicating the presence of voltage gradient between the 2 regions during the repolarization phase.
Those observations were concordant with findings in animal preparations. 21 Nagase et al 30 recorded the local epicardial electrogram of the RVOT in 5 Brugada patients, using an electrode introduced into the conus branch of the right coronary artery, and found that the delayed potential (DP) after termination of the QRS complex occurred only in the epicardium, not in the endocardium. The epicardial DP was significantly prolonged after the administration of class Ic agents. They suggested that these findings were caused by a myocardial abnormality of BS, although the true nature of the DP was not defined. As to the genesis of the ventricular arrhythmias, Aiba et al 31 used a high-resolution optical mapping method to examine the repolarization and depolarization abnormalities in the development of both phase 2 reentry and VT/VF in an animal model of BS. Their study results suggested that phase 2 reentry, which can degenerate into VT/VF, is caused by a steep repolarization gradient in the epicardium, but not in the endocardium.
In addition to a repolarization abnormality, altered depolarization is thought to be involved in the ST-segment elevation and development of VT/VF in BS. DPs detected by body surface mapping and by signal-averaged electrocardiography (SAECG) are positive in many cases, especially in subjects showing the coved-type ST elevation, 25, 30, 32 and could be used as a marker for a high risk of cardiac events. 33 Nagase et al observed that this might not simply indicate a repolarization abnormality, but represent a local delay of secondary depolarization (dome) of the plateau phase. 30 The spatial distributions of the depolarization and repolarization abnormalities, using 87-lead body surface potential mapping, disclose that the depolarization abnormalities are distributed homogeneously, whereas the repolarization abnormalities are localized in the RVOT. 34 The identification of mutations of SCN5A encoding the cardiac sodium channel in patients with BS was a strong indication that decreased INa was the main contributing factor to the ST-segment elevation and the genesis of this syndrome. 35 
Genetic Background of BS
Mutations of SCN5A, which encodes the -subunit of the cardiac sodium channel, 35 have been identified as the genetic abnormalities responsible for BS. Another locus on chromosome 3 close to that of SCN5A has also been linked to the syndrome, but no causative gene has been identified. 36 Over 60 mutations have been reported worldwide, but functional studies have been carried out in less than half of them 6, 35, 37 (see also http://www.hgmd.cf.ac.uk/ac/ index.php). In the heterologous expression system, mutated genes result in a loss of channel function either because of a quantitative reduction in functional channels (failure to express eg, retention in the endoplasmic reticulum) or a qualitative or biophysical alteration in channel function (ie, voltage shifts and kinetic changes in activation, inactivation and reactivation, or accelerated access to a slow inactivation). Familial cases of BS show autosomal dominant inheritance, 35 but sporadic cases account for 60-70% of all patients in Europe. 37 In Japan, familial cases are quite rare and most affected individuals are sporadic cases.
The incidence of mutations of SCN5A in BS is reportedly approximately 20% or less in Europe. 28, 37 My survey in 2003 also indicated an incidence of approximately 15% in Japan. 38 During another survey of gene mutations in Japanese Brugada patients, a novel mutation of SCN5A (S1710L) was identified in a patient with idiopathic VF exhibiting rate-dependent RBBB without showing the typical BS-type ECG. 39 Functional assay of this mutated channel disclosed a marked reduction of the INa, with a fast inactivation, a shift in voltage dependence during inactivation and activation, and a slow recovery from inactivation. Since then, the literature describing mutations of SCN5A in Japanese Brugada patients has been accumulating. The mutations are scattered throughout the -subunit of the channel and no hot spots have been identified. 37 To date, mutations found in Japanese subjects have been mainly scattered in Repeat I (D I) and Repeat IV (D IV) of thesubunit (Table 1) , and most have been novel, but there is a certain overlap with those found in patients from other countries. [40] [41] [42] [43] [44] [45] Functional assays of these mutated genes show loss-of-function with different mechanisms 40, [42] [43] [44] [45] (Table 1) . Makita et al reported that the -subunit was responsible for aggravating channel dysfunction in BS and mutations of the sodium channel would cause not only BS, but also the conditions of decreased conduction and excitability. 46 Takehara et al reported a case of BS complicated with atrial standstill and genetic analysis revealed a missence mutation (R367H) in SCN5A. 40 Makiyama et al 45 examined the genotype -phenotype relationship in 38 Japanese patients. Four heterozygous mutations (T187I, D356N, K1578fs/52, and R1623X) were identified in 4 of the 38 patients, who had bradyarrhymic complications (3 sick sinus syndrome and 1 paroxysmal atrioventricular block) and all the mutations encoded non-functional sodium channels. Bradyarrhythmias were complicated in only 2 of 34 patients with non-SCN5A-linked BS. They concluded that loss-of-function SCN5A mutations resulting in BS are distinguished by profound bradyarrhythmias. In contrast, Yokoi et al 42 described a case of asymptomatic BS with double SCN5A mutations (K1527R and A1569P). Functional assay of these mutated genes revealed decreased INa because of a negative shift in steady-state inactivation and enhanced slow inactivation. From the discrepant results for phenotype and genetic abnormalities, they suggested that there are unknown factors or modifier genes influencing arrhythmogenesis.
Not only mutations of SCN5A but also polymorphisms may be involved in the genesis of BS. Bezzina et al demonstrated that an SCN5A promoter polymorphism common in Asians (variant haplotype) was associated with variable conduction abnormalities in subjects, including Japanese BS, 47 which may explain, at least in part, why there is a high prevalence of this syndrome in Japanese.
Clinical Characteristics

General Characteristics
The Table 2 (Takagi et al unpubl data). Over 94% of the cases were men, a higher male/female ratio (≅15/1) than that (≅8-10/1) in the reports mainly from Europe. 2,6,9,10 The mean age was 52 years. The incidence of family history of SCD was approximately 14% in total and a familiar incidence of BS-type ECG was less than 3%; both values were lower than in previous reports. One notable finding was a high incidence of a history of AF, especially in the symptomatic groups (VF and Syncope groups). This high incidence of AF, especially the paroxysmal form, confirmed the findings of Morita et al, who found spontaneous development of AF in 7 of 18 Brugada patients (39%) with increased atrial vulnerability. 48 A high incidence of AF complication may be a characteristic of Japanese patients. A similar multicenter study was conducted under a grant from The Ministry of Health, Labor and Welfare (A Multicenter Study on Prognosis in Patients with BS) for 6 years and the preliminary results, summarized by Kamakura, 49 show a similar profile of Japanese BS patients to the subjects in J-IVFS.
Gender Difference
As to the male predominance, effects of estrogen on Ito have been suggested from the results of animal experiments. 50 An important clinical observation as to a possible involvement of testosterone on ST-segment elevation was reported by Matsuo et al, who observed 2 cases of disappearance of the typical ST-segment elevation of BS after castration for the treatment of prostate cancer, and they suggested testosterone as an important factor in the genesis of this ECG sign. 51 Their findings need further confirmation with a large-scale survey to clarify the role and involvement of testosterone in the genesis of BS.
Factors Influencing ST-Segment Elevation
Multiple factors have been shown to influence ST-segment elevation in BS. The effects of class Ia and Ic agents (sodium-channel blockers) have been described repeatedly in terms of their diagnostic usefulness. 6, 9, 10, 22, 26, 27 Many cardiac and noncardiac drugs acting on the inward and outward currents during the action potential have been shown to affect or unmask ST-segment elevation in symptomatic and asymptomatic patients. 6 Vagal stimulation and vagotonic agents aggravated and/or induced ST-segment elevation in the early report by Kasanuki et al. 32 Because the cardiac events in BS frequently occur during rest and/or sleep, vagotonic conditions might facilitate VT/VF. The previous studies on this issue have disclosed that not only increased vagal tone, but also bradycardia itself, is associated with the abnormal repolarization responses in symptomatic patients. 52, 53 Increased vagal tone and decreased sympathetic activity, assessed by heart rate variability, have been suggested as prominent signs in symptomatic patients with BS. 54 Abnormal MIBG-uptake, indicating presynaptic sympathetic dysfunction, was dominant in cases with the coved-type ST elevation. 55 These observations suggest that a combination of increased vagal tone, decreased sympathetic activity and bradycardia may contribute to the development of cardiac events and symptoms in BS. Effects of insulin on induction and aggravation of ST-segment elevation have also been reported, although the mechanism was not exactly known, but the action of insulin on different ionic channels and/or autonomic functions as a result of food intake might be involved. 56, 57 In conjunction with these studies, Ikeda et al suggested that the "full stomach test" could be a useful provocative procedure for stimulating vagal activity and identifying Type 1 ECG changes in patients at risk of BS. 58 In addition, various cardiac and noncardiac drugs, autonomic changes, electrolyte imbalances, body temperature, tumor and extracardiac mass have been shown to mimic or unmask BS and the BS-type ECG, as acquired forms of BS. 59 Similarity between the ST elevation seen in BS and that seen in coronary vasospasm suggests that the 2 conditions share a common mechanistic background. The incidence of vasospastic angina is relatively high in Japan, as is BS. In fact, Chinushi et al 60 first reported the coexistence of BS and vasospastic angina in 2 cases. They found that 5 of 38 Brugada patients (13.1%) had associated coronary vasospasm and 4 had clinical angina. 61 Two of the 4 patients with vasospastic angina experienced syncope with their ischemic attacks. Noda et al 62 evaluated the frequency of coronary vasospasm, augmentation of ST-segment elevation in V1-3 and induction of VF by intracoronary injection of acetylcholine or ergonovine maleate in 27 symptomatic Brugada patients and 30 control subjects. With right coronary injection of either agent, 3 cases (11%) developed coronary vasospasm, 11 (33%) had aggravation of ST elevation and 3 (9%) showed inducible VF in BS. Neither ST elevation nor VF was observed in any of the control subjects. The researchers suggest that mild ischemia and increased vagal tone may act additively or synergistically with the substrate responsible for BS in favor of ST-segment elevation and the occurrence of VF.
Risk Stratification of BS
Risk stratification of patients for SCD is an important issue in the management of actual and suspected cases of BS. Brugada et al found that patients with aborted SCD had the highest risk for recurrence (69%) and those with syncope had a recurrence rate of 19%, whereas asymptomatic patients showed an 8% rate of recurrence. 63 Spontaneous appearance of Type 1 ST-segment elevation was also suggested as a marker of high risk, whereas ST elevation that developed only after a provocation test with sodiumchannel blockers may indicate minimal risk. 64 Male BS patients with inducible VT/VF, a family history of SCD and spontaneous ST-segment elevation are suggested to be at higher risk. 6, 63, 64 Whether this schema for risk stratification is applicable to Japanese patients or not is an important and unsettled issue. In a follow-up study of Brugada patients by Kamakura 49 for a mean of 46 months, there were 32 cases of cardiac events. The annual rate of cardiac events was 10.7% in the VF group and 0.4% in the asymptomatic group. In J-IVFS, we followed for a mean of 36 months 182 patients who had survived more than 1 year after enrollment and found cardiac events in 15 of 94 symptomatic cases (VF and syncope groups) (16%) but none in the 88 asymptomatic cases (unpubl data). The Japanese results confirm that symptomatic patients (VF and syncope groups) have higher rates of recurrence than asymptomatic patients, but overall rates of cardiac events are much less than in patient populations in foreign studies. 63, 64 In particular, cardiac events in the asymptomatic group had a much lower incidence in Japanese patients than in their European counterparts, which may reflect the different patient populations, because the European studies mainly deal with probands and their family members, whereas the Japanese studies include mostly probands without a family history. In addition to the coved-type (Type 1) ST-segment elevation, various ECG parameters have been suggested as markers of high risk for the development of cardiac events. Atarashi et al examined Japanese Brugada patients and found that a prolonged r' in V1-3 or S in V5 and V6 were signs of high risk for cardiac events. 65 Our preliminary results from J-IVFS also indicate a higher incidence of prolonged QRS in V1-3, especially the r-J interval (the interval from the beginning of the r wave to the J-point) (Fig 1) , in symptomatic patients compared with asymptomatic groups (unpubl data). Ikeda et al reported that positive LPs in SAECG could be a good predictor of lifethreatening arrhythmias in BS. 33 Other groups have also indicated that positive LPs and abnormal values on SAECG in symptomatic patients have a high risk for recurrence in cardiac events compared with negative or less abnormal values. 30, [66] [67] [68] However, there are significant numbers of asymptomatic patients who present with positive LPs and abnormal SAECG. Therefore, the high predictive value of LPs seems applicable to symptomatic patients, because most of the studies indicating its usefulness have been done at institutions dealing with many symptomatic patients. The value of positive LPs for predicting cardiac events in our large-scale study of patients including many asymptomatic cases, however, appears not so specific, because J-IVFS did not show any difference in the positive rates of LPs between symptomatic and asymptomatic groups (unpubl data). It should be noted that the finding of positive LPs also fluctuates on a daily basis, as does ST elevation. 68, 69 Therefore, the presence of positive LPs is not the single parameter for prediction of cardiac events.
Inducible VT/VF by programmed ventricular stimulation (PVS) has been suggested as a good indicator for predicting high risk in patients with BS, 63, 70 but is still controversial because results from other groups in Europe do not agree with its high predictive value. 64, 71 The protocol of PVS and the endpoints of the study were highly variable among the different institutions, which makes it difficult to interpret the results. Various studies have explored the predictive efficacy of inducible VT/VF as a marker for recurrence of cardiac events in Japanese Brugada patients, but most of them did not reveal a high predictive value for cardiac events. In patients with inducible VT/VF compared with non-inducible cases, there was a high incidence of abnormal electrophysiological parameters, including conduction and refractoriness, but inducibility itself could not predict the recurrence of cardiac events. 72, 73 Inducible VT/VF after the administration of sodium-channel blockers was also assessed for its usefulness as a marker of cardiac events, but no strong evidence was achieved and no large-scale trials to confirm its usefulness in Japanese patients have been conducted so far.
Therapeutic Aspects of BS
The only and the best therapeutic means of preventing SCD of BS patients is ICD implantation. Therefore, the patients with aborted SCD or documented VF should be treated by ICD, Because these patients are prone to recurrence of cardiac events. Syncope of unknown etiology is also considered an indication for ICD implantation, if patients show spontaneous ST elevation associated with a family history of SCD, or inducible VT/VF. 6, 9, 10 In asymptomatic patients, ICD implantation is generally not recommended, because of the good prognosis, but the indication should be individualized according to the presence or absence of the multiple factors (ie, male, spontaneous ST elevation, family history of SCD, inducible VT/VF, results of drug provocation test and positive LPs).
Drug treatments for BS are not feasible at the present time, because no single drug has been shown to successfully prevent cardiac events. Drug treatments are, therefore, indicated only as an adjunct under certain conditions, such as the acute phase of repeated VF episodes, electrical storms after ICD implantation, or patients who refuse implantation. Isoproterenol infusion has been effective for repeated VF episodes in the acute phase and for VF storms after ICD implantation. 74 Experiences from Japanese institutions indicate cilostazol 75 and low-dose quinidine treatment 76 as adjunctive therapy. Isoproterenol is supposed to increase the L-type Ca 2+ current and cilostazol is an inhibitor of phosphodiestrase, which increases intracellular cyclic AMP and thus increases the L-type Ca 2+ current. Quinidine has multiple actions on ionic currents and a potent inhibitory action on Ito. The actions of these agents are supposed to the decrease voltage gradient in the early phase of the plateau and repolarization at the RVOT. Other agents that exhibit similar actions to isoproterenol, cilostazol or quinidine are expected to exert positive effects, but so far none have been proven effective in many patients with BS.
Conclusion
BS has a relatively high incidence in Japan and is a major cause of SCD in apparently healthy individuals. Patients with aborted SCD with spontaneous ST-segment elevation are at high risk for recurrence of cardiac events. However, there is no single parameter for predicting that risk or the recurrence of cardiac events, but risk stratification can be considered by reviewing multiple factors, including spontaneous ST elevation, prolonged r-J interval in V1-3, family history of SCD, inducible VT/VF, positive provocation test with class Ic agents and positive LPs. The prognosis of asymptomatic patients is generally seems good, with certain exceptional cases. The identification of these asymptomatic patients at risk awaits further results of large-scale, long-term studies.
